p53 Protein in Low-Grade Astrocytomas
Author Information
Author(s): P. Iuzzolino, C. Ghimenton, A. Nicolato, F. Giorgiutti, P. Fina, C. Doglioni, M. Barbareschi
Primary Institution: Ospedale Civile Maggiore, Verona, Italy
Hypothesis
Is p53 protein accumulation a significant prognostic factor in low-grade astrocytomas?
Conclusion
p53 protein accumulation is common in low-grade astrocytomas but does not significantly affect survival outcomes.
Supporting Evidence
- p53 accumulation was seen in 46.1% of patients.
- Median survival for p53-positive patients was 41 months.
- Median survival for p53-negative patients was 37 months.
- Five years after diagnosis, survival estimate was 21.2% for p53-positive and 45.9% for p53-negative patients.
Takeaway
This study looked at a protein called p53 in brain tumors called low-grade astrocytomas. It found that while many tumors had this protein, it didn't really change how long patients lived.
Methodology
The study examined surgically resected specimens of 66 grade II human astrocytomas and evaluated p53 protein expression using immunohistochemistry.
Potential Biases
Potential bias due to the small number of patients alive after 5 years, which limits the analysis of survival differences.
Limitations
The study had a small sample size and the follow-up period may not have been long enough to observe significant differences in survival.
Participant Demographics
Mean age of patients was 37.4 years, with a range from 16 to 74 years.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website